New Drug for H1N1 Flu Offers Hope

widely available is coming from investors in BioCryst, including Kleiner Perkins Caufield & Byers, the prominent Silicon Valley venture capital firm. John Doerr, the companys technology guru, was in Washington this week making the case for greater...